The V1a and V1b, but not V2, vasopressin receptor genes are expressed in the supraoptic nucleus of the rat hypothalamus, and the transcripts are essentially colocalized in the vasopressinergic magnocellular neurons

被引:82
|
作者
Hurbin, A [1 ]
Boissin-Agasse, L [1 ]
Orcel, H [1 ]
Rabié, A [1 ]
Joux, N [1 ]
Desarménien, MG [1 ]
Richard, P [1 ]
Moos, FC [1 ]
机构
[1] CNRS, Ctr Pharmacol Endocrinol, UPR 9055, F-34094 Montpellier 05, France
关键词
D O I
10.1210/en.139.11.4701
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have identified and visualized the vasopressin (VP) receptors expressed by hypothalamic magnocellular neurons in supraoptic and paraventricular nuclei. To do this, we used RT-PCR on total RNA extracts from supraoptic nuclei or on single freshly dissociated supraoptic neurons, and in situ hybridization on frontal sections of hypothalamus of Wistar rats. The RT-PCR on supraoptic RNA extracts revealed that mainly V-1a, but also V-1b, subtypes of VP receptors are expressed from birth to adulthood. No V-2 receptor messenger RNA (mRNA) was detected. Furthermore, the single-cell RT-nested PCR indicated that the V-1a receptor mRNA is present in vasopressinergic magnocellular neurons. In light of these results, in situ hybridization was performed to visualize the V-1a and V-1b receptor mRNAs in supraoptic and paraventricular nuclei. Simultaneously, we coupled this approach to: 1) in situ hybridization detection of oxytocin or VP mRNAs; or 2) immunocytochemistry to detect the neuropeptides. This provided a way of identifying the neurons expressing perceptible amounts of V-1a or V-1b receptor mRNAs as vasopressinergic neurons. Here, we suggest that the autocontrol exerted specifically by VP on vasopressinergic neurons is mediated through, at least, V-1a and V-1b subtype receptors.
引用
收藏
页码:4701 / 4707
页数:7
相关论文
共 50 条
  • [31] Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents
    Manning, Maurice
    Stoev, Stoytcho
    Chini, Bice
    Durroux, Thierry
    Mouillac, Bernard
    Guillon, Gilles
    ADVANCES IN VASOPRESSIN AND OXYTOCIN: FROM GENES TO BEHAVIOUR TO DISEASE, 2008, 170 : 473 - 512
  • [32] Response to endogenous and exogenous vasopressin V2 receptor stimulation is intact in mice lackingV1a or V1b receptors
    Mori, T
    Kinoshita, S
    Fujiki, H
    Nakamura, S
    Miyazaki, T
    Itoh, S
    Tsunoue, A
    Tsujimoto, G
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 97 : 252P - 252P
  • [33] MOLECULAR-CLONING AND EXPRESSION OF RAT V1A AND V2 ARGININE-VASOPRESSIN RECEPTORS
    MOREL, A
    LOLAIT, SJ
    BROWNSTEIN, MJ
    REGULATORY PEPTIDES, 1993, 45 (1-2) : 53 - 59
  • [34] Pharmacological characterization of RWJ-676070, a dual vasopressin V1A/V2 receptor antagonist
    Gunnet, Joseph W.
    Wines, Pamela
    Xiang, Min
    Rybczynski, Philip
    Andrade-Gordon, Patricia
    de Garavilla, Lawrence
    Parry, Tom J.
    Cheung, Wai-man
    Minor, Lisa
    Demarest, Keith T.
    Maryanoff, Bruce E.
    Damiano, Bruce P.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 590 (1-3) : 333 - 342
  • [35] Dual V1a/V2 versus selective V2 vasopressin receptor blockade in a preclinical heart failure model: does it matter?
    Mondritzki, T.
    Pook, E.
    Wasnaire, P.
    Schmeck, C.
    Kolkhof, P.
    EUROPEAN HEART JOURNAL, 2016, 37 : 1317 - 1317
  • [36] Mutagenesis of endogenous cysteine residues in human V1a and V2 vasopressin receptors
    Loh, ED
    Tharian, A
    Pratt, B
    Johnson, MP
    Kolakowski, LF
    FASEB JOURNAL, 1997, 11 (09): : A1340 - A1340
  • [37] Alterations of renal vasopressin V1A and V2 receptors in spontaneously hypertensive rats
    Tahara, A
    Tsukada, J
    Tomura, Y
    Wada, K
    Kusayama, T
    Ishii, N
    Yatsu, T
    Uchida, W
    Taniguchi, N
    Tanaka, A
    PHARMACOLOGY, 2003, 67 (02) : 106 - 112
  • [38] Fluorescent agonists for the human vasopressin V1b receptor
    Guillon, G.
    Murat, B.
    Corbani, M.
    Boulay, V
    Stoev, S.
    Manning, M.
    JOURNAL OF PEPTIDE SCIENCE, 2008, 14 (08) : 116 - 116
  • [39] Characterization of vasopressin V1b receptor deficient mouse
    Oshikawa, S
    Tanoue, A
    Ito, S
    Fukuda, M
    Yamamoto, K
    Tsujimoto, G
    JAPANESE JOURNAL OF PHARMACOLOGY, 2002, 88 : 213P - 213P
  • [40] Vasopressin V1B Receptor Antagonists as Potential Antidepressants
    Chaki, Shigeyuki
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2021, 24 (06): : 450 - 463